Thermo Fisher Scientific | TMO - Cost Of Sales


Thermo Fisher Scientific reported $7.54B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Agilent USD 836M 9M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Bio Techne USD 103.13M 1.47M Mar/2026
Bio-Rad Laboratories USD 305.2M 22.5M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Bruker USD 422.5M 21.1M Jun/2026
Charles River Laboratories USD 655.29M 61.22M Jun/2026
Danaher USD 2.65B 294M Jun/2026
Dentsply International USD 405M 48M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
General Electric Aerospace USD 8.89B 736M Jun/2026
Henry Schein USD 2.43B 129M Jun/2026
Illumina USD 389M 19M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Laboratory Of America USD 2.7B 97.8M Jun/2026
Medtronic USD 3.83B 26M Jun/2026
Mettler Toledo International USD 396.52M 14.4M Jun/2026
Myriad Genetics USD 63M 1.1M Dec/2025
Olympus JPY 83.57B 18.95B Jun/2026
OraSure Technologies USD 15.43M 113K Dec/2025
Quest Diagnostics USD 2.05B 64M Jun/2026
Repligen USD 94.09M 8.12M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
Veracyte USD 42.19M 3.7M Jun/2026
Waters USD 1.16B 430M Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026